Skip to main content
. 2016 Apr 2;71(Suppl 1):i21–i31. doi: 10.1093/jac/dkw070

Figure 1.

Figure 1.

Percentage susceptibility rates (with 95% confidence intervals) for antimicrobials against S. pneumoniae by country according to CLSI breakpoints. aAzithromycin was not tested in Ivory Coast. bSample sizes in Kenya were: azithromycin and erythromycin, n = 64; levofloxacin, n = 20. cAmoxicillin/clavulanic acid was not tested in Democratic Republic of Congo. In Senegal only 14 S. pneumoniae isolates were collected. Therefore Senegal data have not been included in this figure. AMC, amoxicillin/clavulanic acid; SXT, trimethoprim/sulfamethoxazole.